Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Feb 17;12(10):5919-5927.
doi: 10.1039/d1ra07438e. eCollection 2022 Feb 16.

A multi pathway coupled domino strategy: I2/TBHP-promoted synthesis of imidazopyridines and thiazoles via sp3, sp2 and sp C-H functionalization

Affiliations

A multi pathway coupled domino strategy: I2/TBHP-promoted synthesis of imidazopyridines and thiazoles via sp3, sp2 and sp C-H functionalization

Yishou Wang et al. RSC Adv. .

Abstract

I2/TBHP-promoted, one-pot, multi pathway synthesis of imidazopyridines and thiazoles has been achieved through readily available ethylarenes, ethylenearenes and ethynearenes. I2/TBHP as an initiator and oxidant is used to realize the C-H functionalization of this domino reaction. Simple and available starting materials, wide range of functional group tolerance, high potential for drug activity of the products and application in production are the advantageous features of this method.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts to declare.

Figures

Scheme 1
Scheme 1. The drugs and biologically active compounds containing imidazopyridines or thiazoles units.
Scheme 2
Scheme 2. Approach for the synthesis of imidazo[1,2-a]pyridine and thiazole.
Scheme 3
Scheme 3. Gram-scale synthesis of 3aa and 3ak. aReaction conditions: 1a (10 mmol), I2 (4 mmol), TBHP (30 mmol), 120 °C, 1 h 10 min then 2-aminopyridine (20 mmol), CuCl2 (5 mmol), solvent (20 mL), 110 °C, 4 h. bReaction conditions: 1a (2 mmol), 3a (2 mmol), 4a (2 mmol), I2 (2.4 mmol), TBHP (18 mmol), 120 °C, 1 h 20 min then 2-aminopyridine (12 mmol), CuCl2 (3 mmol), solvent (10 mL), 110 °C, 2.5 h. cReaction conditions: 1a (2 mmol), 3a (2 mmol), 4a (2 mmol), I2 (2.4 mmol), TBHP (18 mmol), 120 °C, 1 h 20 min then 2k (12 mmol), CuCl2 (3 mmol), solvent (10 mL), 110 °C, 2 h.
Scheme 4
Scheme 4. The control experiments.
Scheme 5
Scheme 5. The proposed reaction mechanism.

References

    1. Sayeed I. B. Lakshma Nayak V. Shareef M. A. Chouhan N. K. Kamal A. MedChemComm. 2017;8:1000–1006. doi: 10.1039/C7MD00043J. - DOI - PMC - PubMed
    2. Lefin R. van der Walt M. M. Milne P. J. Terre'Blanche G. Bioorg. Med. Chem. Lett. 2017;27:3963–3967. doi: 10.1016/j.bmcl.2017.07.071. - DOI - PubMed
    3. Santaniello B. S. Price M. J. Murray Jr J. K. J. Chem. Educ. 2017;94:388–391. doi: 10.1021/acs.jchemed.6b00286. - DOI
    4. Katritzky A. R. Xu Y. J. Tu H. J. Org. Chem. 2003;68:4935–4937. doi: 10.1021/jo026797p. - DOI - PubMed
    5. Martin R. Rodriguez Rivero M. Buchwald S. L. Angew. Chem., Int. Ed. 2006;45:7079–7082. doi: 10.1002/anie.200602917. - DOI - PubMed
    1. Stasyuk A. J. Banasiewicz M. Cyrań ski M. K. Gryko D. T. J. Org. Chem. 2012;77:5552–5558. doi: 10.1021/jo300643w. - DOI - PubMed
    1. Langer S. Z. Arbilla S. Benavides J. Scatton B. Adv. Biochem. Psychopharmacol. 1990;46:61. - PubMed
    2. Mizushige K. Ueda T. Yukiiri K. Suzuki H. Cardiovasc. Drug Rev. 2002;20:163. doi: 10.1111/j.1527-3466.2002.tb00085.x. - DOI - PubMed
    3. Almirante L. Polo L. Mugnaini A. Provinciali E. Rugarli P. Biancotti A. Gamba A. Murmann W. J. Med. Chem. 1965;8:305. doi: 10.1021/jm00327a007. - DOI - PubMed
    4. Boerner R. J. Moller H. J. Psychopharmakother. 1997;4:145.
    5. Gunaganti N. Kharbanda A. Lakkaniga N. R. Zhang L. Cooper R. Li H. Y. Frett B. Chem. Commun. 2018;54:12954–12957. doi: 10.1039/C8CC07063F. - DOI - PMC - PubMed
    6. Guo T. Liang J. J. Yang S. Chen H. Fu Y. N. Han S. L. Zhao Y. H. Org. Biomol. Chem. 2018;16:6039–6046. doi: 10.1039/C8OB01263F. - DOI - PubMed
    1. Ulloora S. Adhikari A. V. Shabaraya R. Chin. Chem. Lett. 2013;24:853–856. doi: 10.1016/j.cclet.2013.05.030. - DOI
    2. Herath A. Dahl R. Cosford N. D. P. Org. Lett. 2010;12:412–415. doi: 10.1021/ol902433a. - DOI - PMC - PubMed
    1. Feng M.-L. Li S.-Q. Chen S.-Y. Yu X.-Q. Green Chem. 2019;21:1619–1624. doi: 10.1039/C8GC03622E. - DOI
    2. Mohan D. C. Rao S. N. Ravi C. Adimurthy S. Asian J. Org. Chem. 2014;3:609–613. doi: 10.1002/ajoc.201402004. - DOI
    3. Ge W. Zhu X. Wei Y. Eur. J. Org. Chem. 2013;27:6015–6020. doi: 10.1002/ejoc.201300905. - DOI